content_image/147142.jpg content_image/147141.jpg content_image/147140.jpg
## Notes to the Consolidated Financial Statements — (Continued) 

## MetLife, Inc. 

<img src='content_image/147142.jpg'>

Information regarding other policy-related intangibles was as follows: 

<img src='content_image/147141.jpg'>

(1) In connection with the Company’s annual impairment testing of VOCRA, it was determined that the VOCRA included in the Group, Voluntary & Worksite Benefits segment, associated with a previously acquired dental business, was impaired as the undiscounted future cash flows associated with the asset were lower than its current carrying value. This shortfall in undiscounted future cash flows is primarily the result of actual persistency experience being less favorable than what was assumed when the asset was acquired. As a result of this impairment, the Company wrote the asset down to its estimated fair value, which was determined using the discounted cash flow valuation approach. The Company recorded a non- cash charge of $77 million ($50 million, net of income tax) for the impairment of the VOCRA balance to other expenses in the consolidated statement of operations for the year ended December 31, 2012. 

The estimated future amortization expense (credit) to be reported in other expenses for the next five years is as follows: 

<img src='content_image/147140.jpg'>

